Congress Materials

As part of our commitment to addressing unmet medical needs, Corcept investigates approved products and pipeline compounds and indications. Corcept presents its research at major congress events globally.

 

The content contained herein is for your information only. No reproduction, alteration, or distribution of this information is permitted. The safety and efficacy of investigational compounds or investigational uses of marketed products have not been established. These uses have not been approved by the US Food and Drug Administration or other regulatory authorities.

 

Access Corcept congress presentations below.

Filter by:

Aroda VR

American Diabetes Association

2025

Final Results of the CATALYST Trial

Fonseca V

Association of Diabetes Care & Education Specialists

2025

Final Results of the CATALYST Trial

DeFronzo RA, Fonseca V, Aroda VR

Hamrahian A, Aresta C, Badiu C, et al

Pivonello R, Arnaldi G, Auchus RJ, et al

Fonseca V, Aroda VR, Budoff M, et al.

Handelsman, Y, Aroda VR, Bailey T, et al.

Auchus RJ, Gilis-Januszewska A, Badiu C, et al

World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease

2024

Medical treatment of hypercortisolism with relacorilant: final results of the phase 3 grace study

Piconello R, Arnaldi G, Auchus RJ, et al

Gilis-Januszewska A, Badiu C, Ranetti A-E, et al

East HE, Moraitis AG, Belanoff J

American Association of Clinical Endocrinology

2022

Mifepristone use in hypercortisolism from an unknown source: a case study

Brown DR, Ray R

Greenstein AE, Habra MA, Mura M, Biernat P, Piatek MJ, Grauer A, Shepherd SP

Terzolo M, Iacuaniello D, Pia A, Adriano P, Moriatis A, Pivonello R

Jerkins TW, Jerkins RK, Ray R

Sachmechi I, Alkomos MF, Zarghamravanbaksh P, Mahendhar R, Palaniswamy K

Bancos I, Hatipoglu BA, Ji Yuen KC, Moriatis A

Moraitis AG, Agrawal N, Bancos I, Celo FS, Gordon MB, Kargi AY, Lerman S, Mariash CN, Silverstein JM, Weirman ME